Zobrazeno 1 - 1
of 1
pro vyhledávání: '"B. Zorkany"'
Autor:
A. Deodhar, S. Akar, J. Curtis, B. Zorkany, M. Magrey, C. Wang, J. Wu, S. B. Makgoeng, I. Vranic, S. Menon, D. Fleishaker, A. Diehl, L. Fallon, A. Yndestad, R. B. M. Landewé
Publikováno v:
Annals of the Rheumatic Diseases. 81:394-395
BackgroundTofacitinib is an oral JAK inhibitor for the treatment of adults with ankylosing spondylitis (AS).ObjectivesTo describe the tofacitinib safety profile from an integrated analysis of randomised controlled trials (RCTs) in patients (pts) with